Post-Transplant Lymphoproliferative Disorders after Allogeneic Hematopoietic Stem Cell Transplantation: Case Report and Literature Review
Received Date: Aug 31, 2021 / Accepted Date: Sep 14, 2021 / Published Date: Sep 21, 2021
Abstract
PTLDs are disorders with a spectrum ranging from “early” polyclonal proliferations resembling nonspecific plasma cell hyperplasia or infectious mononucleosis to clonal proliferations of B or T/NK cells. The incidence of PTLD after HSCT is approximately 0.8%-4.0%. The clinical manifestations of PTLD are variable related to the morphological types, sites, and patient’s general condition. Four basic histological types of PTLD have been identified: Nondestructive PTLD, polymorphic PTLD, monomorphic PTLD and classical Hodgkin Lymphoma. Treatments for PTLD comprise reduction of immunosuppression, rituximab, chemotherapy, and adoptive immunotherapy.
Keywords: Hematopoietic stem cell transplantation; Post-transplant lymphoproliferative disorders; Leukemia; Epstein-Barr virus
Citation: Chen D, Jiang , Shen D (2021) Post-Transplant Lymphoproliferative Disorders After Allogeneic Hematopoietic Stem Case Report and Literature Review. J Clin Exp Pathol 11: 397.
Copyright: © 2021 Chen D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Usage
- Total views: 1380
- [From(publication date): 0-2021 - Apr 29, 2024]
- Breakdown by view type
- HTML page views: 941
- PDF downloads: 439
